Physician profile

Patrick David Bauer

Orthopaedic Surgery · Jeffersonville, IN

NPI 1902896186

$713.16

in general payments reported to CMS, 2019-2025

9 companies · none reported in 2025

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$132.63

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Sanofi-Aventis U.S. LLC $192.30 2019-2023
Pacira Therapeutics, INC. $138.83 2019-2020
Zimmer Biomet Holdings, INC. $119.54 2019-2020
Ferring Pharmaceuticals INC. $101.22 2019-2023 Euflexxa
Pacira Pharmaceuticals Incorporated $47.17 2023 Iovera, Zilretta, Exparel
Depuy Synthes Sales INC. $45.12 2019-2022
Heraeus Medical, LLC. $42.82 2021
Alpha Orthopedic Systems $13.21 2023
Zyla Life Sciences, INC. $12.95 2020

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Patrick David Bauer

$713.16

in general payments reported 2019-2025

Years
2019-2023
Top company
Sanofi-Aventis U.S. LLC

https://glasscript.com/doctor/446270/patrick-david-bauer

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.